Similar Items: Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms ≤20 mm: a population-based SEER analysis
- Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experience
- Patient-reported symptom and urgent healthcare use in neuroendocrine tumors
- Mesenteric paraganglioma mimicking nodal metastasis of an occult small intestinal neuroendocrine tumor
- Prognostic and therapeutic roles of specific genotypes through target-gene sequencing on gastroenteropancreatic neuroendocrine carcinoma
- Trends in metastatic thyroid cancer survival from 1992 to 2022: a SEER database analysis
- Metastatic neuroendocrine lesions in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): a narrative review and case series